Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Cataract and the use of statins: a case-control study.

Smeeth L, Hubbard R, Fletcher AE.

QJM. 2003 May;96(5):337-43.

PMID:
12702782
2.

A population based case-control study of cataract and inhaled corticosteroids.

Smeeth L, Boulis M, Hubbard R, Fletcher AE.

Br J Ophthalmol. 2003 Oct;87(10):1247-51.

3.

The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.

Koro CE, Sowell MO, Stender M, Qizilbash N.

Clin Ther. 2008 Mar;30(3):535-42. doi: 10.1016/j.clinthera.2008.02.008.

PMID:
18405791
4.

Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.

Rejnmark L, Vestergaard P, Mosekilde L.

Calcif Tissue Int. 2006 Jul;79(1):27-36. Epub 2006 Jul 24.

PMID:
16868664
5.

Statins and risk of polyneuropathy: a case-control study.

Gaist D, Jeppesen U, Andersen M, García Rodríguez LA, Hallas J, Sindrup SH.

Neurology. 2002 May 14;58(9):1333-7.

PMID:
12011277
6.

Statin use and risk of colorectal cancer.

Coogan PF, Smith J, Rosenberg L.

J Natl Cancer Inst. 2007 Jan 3;99(1):32-40.

PMID:
17202111
7.

Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy.

Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts AC.

Neurology. 2006 May 9;66(9):1318-24.

PMID:
16682661
8.

Recent statin use and cataract surgery.

Fong DS, Poon KY.

Am J Ophthalmol. 2012 Feb;153(2):222-228.e1. doi: 10.1016/j.ajo.2011.08.001. Epub 2011 Oct 6.

PMID:
21982100
10.
11.

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

Boudreau DM, Gardner JS, Malone KE, Heckbert SR, Blough DK, Daling JR.

Cancer. 2004 Jun 1;100(11):2308-16.

12.

Chronic statin therapy and the risk of colorectal cancer.

Yang YX, Hennessy S, Propert K, Hwang WT, Sarkar M, Lewis JD.

Pharmacoepidemiol Drug Saf. 2008 Sep;17(9):869-76. doi: 10.1002/pds.1599.

PMID:
18412290
13.

Hip fracture risk in statin users--a population-based Danish case-control study.

Rejnmark L, Olsen ML, Johnsen SP, Vestergaard P, Sørensen HT, Mosekilde L.

Osteoporos Int. 2004 Jun;15(6):452-8. Epub 2004 Feb 17.

PMID:
15205716
14.

Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study.

Sailler L, Pereira C, Bagheri A, Uro-Coste E, Roussel B, Adoue D, Fournie B, Laroche M, Zabraniecki L, Cintas P, Arlet P, Lapeyre-Mestre M, Montastruc JL.

Ann Rheum Dis. 2008 May;67(5):614-9. Epub 2007 Sep 3. Erratum in: Ann Rheum Dis. 2008 Aug;67(8):1200. Roussel, H [corrected to Roussel, B]; Arlet-Suau, E [removed].

PMID:
17768174
15.

[Concomitant use of statins and cytochrome P 450 inhibitors in Croatia].

Reiner Z, Galić M, Hanzevacki M, Tedeschi-Reiner E.

Lijec Vjesn. 2005 Mar-Apr;127(3-4):65-8. Croatian.

PMID:
16193855
16.

Impact of better adherence to statin agents in the primary prevention of coronary artery disease.

Perreault S, Dragomir A, Blais L, Bérard A, Lalonde L, White M, Pilon D.

Eur J Clin Pharmacol. 2009 Oct;65(10):1013-24. doi: 10.1007/s00228-009-0673-0. Epub 2009 Jun 16.

PMID:
19529927
17.

Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization.

Shanahan RL, Kerzee JA, Sandhoff BG, Carroll NM, Merenich JA.

Pharmacotherapy. 2005 Mar;25(3):345-51.

PMID:
15843281
18.

HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis.

Ramcharan AS, Van Stralen KJ, Snoep JD, Mantel-Teeuwisse AK, Rosendaal FR, Doggen CJ.

J Thromb Haemost. 2009 Apr;7(4):514-20. doi: 10.1111/j.1538-7836.2008.03235.x. Epub 2008 Nov 24.

19.

Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans.

Khurana V, Sheth A, Caldito G, Barkin JS.

Pancreas. 2007 Mar;34(2):260-5.

PMID:
17312467
20.

Statin use and the long-term risk of incident cataract: the Blue Mountains Eye Study.

Tan JS, Mitchell P, Rochtchina E, Wang JJ.

Am J Ophthalmol. 2007 Apr;143(4):687-9. Epub 2006 Dec 20.

PMID:
17386279

Supplemental Content

Support Center